首页> 外文期刊>The Veterinary Record >Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK.
【24h】

Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK.

机译:两种新型杯状病毒疫苗株的抗体具有中和来自英国的猫杯状病毒分离株的能力。

获取原文
获取原文并翻译 | 示例
       

摘要

This study examined a panel of 110 uk field isolates of feline calicivirus (fcv) for susceptibility to cross-neutralisation by a panel of eight antisera raised in cats infected with fcv strains F9, 255, fcvg1 and fcv431. The pairs of antisera raised against F9 or 255, neutralised 20 and 21 per cent or 37 and 56 per cent of field strains of virus respectively. In contrast, the pairs of antisera raised against the newer vaccine strains fcvg1 or fcv431 neutralised 29 and 70 per cent or 67 and 87 per cent of field strains respectively. Antisera raised against the two newer strains, namely fcvg1 and fcv431, neutralised a greater proportion of field strains of calicivirus than antisera raised against the older fcv vaccine strains F9 and 255.
机译:这项研究检查了一组110 uk场猫杯状病毒(fcv)分离株是否具有交叉感染的敏感性,这是由感染fcv株F9、255,fcvg1和fcv431的猫中产生的八个抗血清组成的。这些针对F9或255的抗血清分别中和了20%和21%的病毒或37%和56%的野病毒。相比之下,针对新型疫苗菌株fcvg1或fcv431产生的抗血清对分别中和了田间菌株的29%和70%,或67%和87%。与针对较新的fcv疫苗菌株F9和255产生的抗血清相比,针对这两种较新的菌株fcvg1和fcv431产生的抗血清中和了杯状病毒的现场菌株比例更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号